NCT01147692View on ClinicalTrials.gov

A Drug Interaction Study of Simvastatin and Albiglutide

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 19, 2010

Primary Completion Date

August 27, 2010

Study Completion Date

August 27, 2010

Conditions
Diabetes Mellitus, Type 2
Interventions
BIOLOGICAL

simvastatin plus albiglutide

A single dose of 80mg simvastatin on Day 1 followed by 5 weekly doses of subcutaneous albiglutide followed by a single dose of 80mg simvastatin on Day 38.

Trial Locations (1)

78744

GSK Investigational Site, Austin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01147692 - A Drug Interaction Study of Simvastatin and Albiglutide | Biotech Hunter | Biotech Hunter